Clinical features and treatment outcomes of Hodgkin's lymphoma in Hong Kong Chinese. - Wikidata - awgldk - TriplyDB

Clinical features and treatment outcomes of Hodgkin's lymphoma in Hong Kong Chinese.

Clinical features and treatment outcomes of Hodgkin's lymphoma in Hong Kong Chinese.

http://www.wikidata.org/entity/Q33935351

about

Clinical features and treatment outcomes of Hodgkin's lymphoma in Hong Kong Chinese.

http://www.wikidata.org/entity/Q33935351

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Clinical features and treatment outcomes of Hodgkin's lymphoma in Hong Kong Chinese.

@ast

Clinical features and treatment outcomes of Hodgkin's lymphoma in Hong Kong Chinese.

@en

type

label

Clinical features and treatment outcomes of Hodgkin's lymphoma in Hong Kong Chinese.

@ast

Clinical features and treatment outcomes of Hodgkin's lymphoma in Hong Kong Chinese.

@en

prefLabel

Clinical features and treatment outcomes of Hodgkin's lymphoma in Hong Kong Chinese.

@ast

Clinical features and treatment outcomes of Hodgkin's lymphoma in Hong Kong Chinese.

@en

P1433

Q33935351-6BC86D86-59FF-4741-9766-97C6E277140D

P1476

Q33935351-D3F133CF-8A6E-44F8-B4D5-F9152D6A2968

P2093

Q33935351-0B0C8766-A1B7-4C88-902D-E2760D3FB7CE

Q33935351-259148C2-C8D5-4262-83E2-6C1269EFBE84

Q33935351-4633542B-8916-49D8-A0EC-0CE5DC8A5F04

Q33935351-4B359832-70D3-45D7-8266-8FF91C69A63B

Q33935351-A6AD4AFB-2FA9-4054-9580-3527FCDD39DA

Q33935351-BE3D1EB2-D42D-46A7-83D2-1B2A47D1B445

Q33935351-E1608A94-DA41-417C-B1B0-6BA256D09757

Q33935351-EB69CB4B-0A58-4E5E-A39A-8C5D138F26A5

Q33935351-FA370755-1FC2-4699-9C2F-AE258F8F8FDD

P2860

Q33935351-0486FFFF-14C9-462C-B9B2-A46495AA1DE0

Q33935351-083CB066-068D-45D5-9C9A-8247B99DC74D

Q33935351-1F118F47-99AD-4B5A-A2C0-DF53BA2759F7

Q33935351-2B956B6D-F7AE-417B-8762-2264F13FF67A

Q33935351-2F57F407-8AEB-4B1A-9B38-05D3EB015260

Q33935351-32A440F8-B988-4A1A-B9C9-BC0AF01EDF9D

Q33935351-3417C056-2733-4B69-9E91-9F16D0856365

Q33935351-36652F12-3FE4-42D9-93F2-67261B4B0DA8

Q33935351-3DB9DF24-FA44-4031-B94C-37C1C6A832F5

Q33935351-4675F810-CA9F-4DA1-875A-7FE8663DCF76

P304

Q33935351-621068F7-6C2E-46E4-B4C3-53788BDE522C

P31

Q33935351-93AD93C1-0765-4B70-A56F-13011DE8C531

P356

Q33935351-3FD73D5C-AB07-445E-B9E7-0A77E9C6192E

P433

Q33935351-4938FE23-A9BE-47D3-8A95-85EAC1DCC92D

P478

Q33935351-6FA5E9D1-1116-4776-BC14-4D9A9BF1CABE

P577

Q33935351-1967E3F6-4249-45B6-A133-5A7973D9A0BF

P5875

Q33935351-EAB266E3-069A-4554-BDC7-44977A074CC0

P698

Q33935351-5173DA66-6012-4080-BF45-C74879FC4A52

P932

Q33935351-248D47F5-0851-4525-A8D3-4998789A474E

P356

AOMS.2014.43744

P1433

Archives of Medical Science

P1476

Clinical features and treatment outcomes of Hodgkin's lymphoma in Hong Kong Chinese.

@en

P2093

Celia Ng

http://www.w3.org/2001/XMLSchema#string

Charlotte Leung

http://www.w3.org/2001/XMLSchema#string

Chung Yin Ha

http://www.w3.org/2001/XMLSchema#string

Hay Nun Chan

http://www.w3.org/2001/XMLSchema#string

Ho Kei Lai

http://www.w3.org/2001/XMLSchema#string

Man Fai Law

http://www.w3.org/2001/XMLSchema#string

Sze Fai Yip

http://www.w3.org/2001/XMLSchema#string

Ting Ying Ng

http://www.w3.org/2001/XMLSchema#string

Yiu Ming Yeung

http://www.w3.org/2001/XMLSchema#string

P2860

Report of the Committee on Hodgkin's Disease Staging Classification

Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP

Dose-Intensification in Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD14 Trial

Epidemiology of classical Hodgkin lymphoma and its association with Epstein Barr virus in Northern China.

Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study.

Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: mature results of a prospective clinical trial.

Abrogation of p53-induced apoptosis by the hepatitis B virus X gene.

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease.

Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.

Randomized comparison of the stanford V regimen and ABVD in the treatment of advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244.

P304

498-504

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5114/AOMS.2014.43744

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264537779

http://www.w3.org/2001/XMLSchema#string

P698

25097580

http://www.w3.org/2001/XMLSchema#string

P932

4107256

http://www.w3.org/2001/XMLSchema#string